Changshu, China

Wanben Gong

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanben Gong. Retrieved from https://idiyas.com/inventor/wanben-gong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wanben Gong: Innovator in Pharmaceutical Compounds

Introduction

Wanben Gong is a notable inventor based in Changshu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work is recognized for its potential applications in various therapeutic areas.

Latest Patents

Wanben Gong holds a patent for a compound titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent showcases his expertise in creating novel chemical entities that may have important uses in medicine. He has 1 patent to his name, reflecting his commitment to advancing pharmaceutical research.

Career Highlights

Gong is currently employed at Suzhou Novartis Technical Development Co., Ltd., where he continues to work on innovative projects. His role at this prominent company allows him to collaborate with other experts in the field and contribute to the development of new therapeutic solutions.

Collaborations

Some of his notable coworkers include Vincent Bordas and Jvan Brun. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for groundbreaking discoveries in pharmaceuticals.

Conclusion

Wanben Gong is a dedicated inventor whose work in pharmaceutical compounds is paving the way for future advancements in medicine. His contributions are vital to the ongoing development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…